Editas cut to equal weight by Wells Fargo over reni-cel positioning
Wells Fargo has downgraded Editas Medicine (NASDAQ:EDIT) to equal weight from overweight, citing potential competition for ...
bovnews48m
How Does Sutro Biopharma Inc (STRO) Stack Up Against Its Industry Peers?
Sutro Biopharma Inc (STRO) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.46 or -16.37% from the prior close of $2.81. The stock opened at $2.79 and touched a low of ...